Gsk Share Discussion Threads

[ny boy] 18/5/2017 22:42

ADR's closed $43.25, /2 / 1.29 about 1676p I think ?

[ny boy] 18/5/2017 20:11

US markets up, these should be back up to test 1650 + tomorrow

[ny boy] 18/5/2017 15:07

Took a spread bet long @ 1630p

[ny boy] 18/5/2017 14:59

Brazil has always been a basket case for years, rife with corruption, they can't govern period, always someone with their grubby fingers in the till. Rich/poor divide growing ever wider there.

[montyhedge] 18/5/2017 13:50

I say 1550p, Dow futures down again, problem is the good, bad and ugly all get hit together. Trump and Brazil spooked the markets.

[ny boy] 18/5/2017 13:43

Could be heading back to 1612p or 1590p, if so, I will add, as divi is attractive.

[alphorn] 18/5/2017 12:19

Held up well until the $ weakened. ;)

[tradermichael] 18/5/2017 10:48

Held up well there for the first 30 minutes today, so I see this a strength after the overnight fall on Wall Street - .... ;0)

[ny boy] 18/5/2017 09:49

Wobbly due to market correction underway, should remain a safe haven stock though.

[montyhedge] 17/5/2017 22:26

Battern down the hatches for tomorrow, Dow been absolutely hammered in US tonight.

[philanderer] 17/5/2017 14:31

'President Erdoğan meets with 40 top US investors in Washington'

....Executives from Abraaj Group, Cargill, CDPQ, Coca Cola, Dow Chemical, European Bank for Reconstruction and Development (EBRD), International Finance Corporation (IFC), GE Aviation, Glaxo Smith Kline, Lockheed Martin, PepsiCo, Raytheon International and Uber were present at the meeting.

[noslien] 17/5/2017 13:38

I can't completely square the Woodford/Questor comments with the latest quarterly report. However, the tone of the comments made seem imply that we are in a continuing bull market where GSK will not grow much but that banks like Lloyds will. If the general market turns sour I am not sure this hypothesis is correct. I would expect defensives like GSK to fare relatively better and I think bank volatility will increase. Lloyds is like a bride on her 3rd honeymoon, everyone wishes her well but look what happened the last 2 times. Good luck to holders of both but I will continue to hold GSK.

[ashbox] 17/5/2017 12:03

Sorry, should have stated that Questor said he had a history of getting the big calls right and were referring to his sale of banks pre the financial crisis and not the recent Lloyd's purchase (which as you say, remains to be proven).
Seems the paper subscribes to the cult of Woodford and doesn't balance the argument with more recent calls that were not so good.

[romeike] 17/5/2017 11:52

Banking remains to be seen. There are good reasons why banking shares are still in the gutter.

[ashbox] 17/5/2017 11:37

Questor aping the Woodford article today, doesn't bring anything new to the party, just says he got his calls on Banking & Tobacco correct. Share price holding up pretty well.

[alphorn] 16/5/2017 19:03

Forex may prove key again.

[ny boy] 16/5/2017 19:02

Close above 1666 is broadly positive, should see a test of 1715p this month, maybe a slight retrace to 1652

[ny boy] 16/5/2017 14:57

Should get a de ent pop if we can break 1666p a bit stubborn at present.

[ny boy] 16/5/2017 13:56

Up against 1666 resistance (last Fri's high)

[ny boy] 16/5/2017 13:49

I ignore these big players, they are often wrong, easy to play with other people's money, when it's your own here, we tend to be more careful as to our approaches, due diligence etc.

Charts don't lie, I use chart technicals as one of many tools.

[romeike] 16/5/2017 13:42

Woody is totally wrong on this one - it is interesting to note that he opted to publicly slag the company off. Looks more like an ego trip to me than a sound investment decision.

[ny boy] 16/5/2017 10:21

Dip buying again, target 1715p the next resistance.

[dr biotech] 16/5/2017 08:51

I don't hold any shares outside of ISA's now, except for a few that are in the -90% club that I may sell at a later date for tax reasons. I have a mix of shares and funds, with the latter becoming more prominent as I have realised that other people are way better at investing than I am. Currently most are aimed at growth but the dividends are about 8k, all of which is reinvested.

I have a lot of woodford -mostly in the main equity fund but also in the patient capital fund that has been a disappointment. I rate him more highly than a broker, but thats as far as it goes. Currently biggest holdings are AV/GSK/LLOY/BARC/NG/BT - FTSE mainstays, and Premier Oil and Mission Marketing Group (AIM). The latter two are more risky but I am comfortable with that.

I like GSK - they are a customer of ours as well a decent income stock. I am currently logged on to their open wifi whist having a free coffee...

[goldpiguk] 16/5/2017 00:11

Hi Dr Biotech,

I am comfortable holding GSK shares. My remaining holding of GSK is outside my ISA and I am happy to retain these for the long term. If in due course the quarterly dividend is reduced a little it would not be a surprise. I regard GSK as a reliable is somewhat pedestrian income generator. Given the changes to the way tax is applied to dividends a stable dividend is ideal for me.

However within my ISA I am now much more income growth orientated. I was very lucky a couple of years ago to make a very large profit on a speculative AIM share and the annual income generated by my ISA has soared from £0 in 2014/15 to an anticipated c.£10,000 in 2017-18.

LLOY has been unloved in the city for years. Many private investors are still overly cautious on banks, yet (excluding RBS) the UK banking sector is moving into a post financial crash era and there are rich pickings to be had. LLOY should be able to increase its dividend by 10%+ a year for the next few years, so selling my GSK shares and increasing my LLOY weighting fits in well with my income growth aspirations.

(I currently hold CNA, HFEL, HSBA, LLOY, RMG, SBRY and VOD in my ISA portfolio.)

Goldpig

[dr biotech] 15/5/2017 22:11

As is often the case with TMF it's an empty article.

Can't compare rise in the share price vs FTSE and ignore the dividends.

Says diversity is its strength but doesn't say why. All you get with takeovers is talk of synergies, I've never heard of a company being taken over for diversity.

I'm comfortable holding here, I have a lot of respect for Woodford but he's not infallible.